• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking

    6/2/25 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care
    Get the next $NIVF alert in real time by email

    BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans to invest US$30 million in staking the digital asset Solana, marking a substantial expansion of the company's digital asset investment strategy. The investment will be funded through existing credit facilities of US$26 million and US$100 million with ATW and White Lion, respectively.

    Solana is recognized as one of the leading blockchain platforms, known for its high-speed transaction processing capabilities and growing ecosystem of decentralized applications. Solana's staking mechanism allows token holders to earn rewards derived from the network's inflation mechanism while simultaneously supporting network security and decentralization. By aligning with Solana, NewGen is strategically positioning to harness the power of a platform that is shaping the future of decentralized technology, offering immense potential for growth and innovation.

    This strategic move builds upon NewGen's initial entry into the digital assets space with a US$1 million Bitcoin investment completed in December 2024. The decision underscores management's continued confidence in the long-term potential of blockchain-based assets and decentralized finance protocols. As part of its expanded digital asset strategy, the Company plans to establish a dedicated subsidiary focused specifically on digital asset operations and investments, providing enhanced operational focus and strategic flexibility as NewGen forges ahead.

    Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, "This investment represents a natural evolution of our digital asset strategy and positions us strategically within the burgeoning digital assets space. The decision to scale our investment from our initial $1 million Bitcoin position to this substantial $30 million Solana commitment reflects our growing conviction in digital assets as a legitimate asset class. We believe Solana's robust ecosystem and staking opportunities provide compelling value creation potential for our shareholders while diversifying our investment portfolio in this transformative technology sector, and we are eager to reap the potential rewards of this staking."

    About NewGen

    NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen's management team collectively has over a decade of experience in the fertility industry. NewGen's clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen's website is not incorporated by reference into this press release, and you should not consider it a part of this press release.

    Forward-Looking Statements

    This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company's future commercial operations, business strategy, and financial condition. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as (i) extreme volatility in the digital asset market; (ii) regulatory uncertainty regarding the classification and treatment of digital assets; (iii) technological vulnerabilities specific to the Solana blockchain, including network outages, transaction failures, or security breaches; (iv) concentration risk from holding a single digital asset; (v) liquidity constraints impacting the ability to execute large transactions; (vi) operational risks related to custody, staking, or transaction execution; (vii) competition from alternative blockchain protocols; (viii) reputational, legal, or financial harm resulting from ecosystem malfunctions or third-party actions; and (ix) constraints in accessing or maintaining credit facilities necessary to fund the investment under the Company's existing facility agreements. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company's annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC's website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

    Investor Relations Contact

    ICR, LLC

    Robin Yang

    Phone: +1 (212) 537-4406

    Email: [email protected]



    Get the next $NIVF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NIVF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NIVF
    SEC Filings

    See more
    • SEC Form 6-K filed by NewGenIvf Group Limited

      6-K - NewGenIvf Group Ltd (0001981662) (Filer)

      6/4/25 12:45:26 PM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form EFFECT filed by NewGenIvf Group Limited

      EFFECT - NewGenIvf Group Ltd (0001981662) (Filer)

      6/4/25 12:15:07 AM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 424B3 filed by NewGenIvf Group Limited

      424B3 - NewGenIvf Group Ltd (0001981662) (Filer)

      6/3/25 4:30:21 PM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care

    $NIVF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by NewGenIvf Group Limited

      SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

      12/5/24 8:23:57 PM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G filed by NewGenIvf Group Limited

      SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

      11/13/24 9:19:27 PM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G filed by NewGenIvf Group Limited

      SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

      10/10/24 3:39:26 PM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care

    $NIVF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking

      BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans to invest US$30 million in staking the digital asset Solana, marking a substantial expansion of the company's digital asset investment strategy. The investment will be funded through existing credit facilities of US$26 million and US$100 million with ATW and White Lion, respectively. Solana is recognized as one of the leading blockchain platforms, known for its high-speed transaction processing capabilities and growing ecosystem of dece

      6/2/25 8:30:00 AM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care
    • NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists

      BANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that its wholly owned subsidiary, First Fertility PGS Center Limited ("First Fertility"), has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments. This initiative positions NewGen to capitalize on Thailand's rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care. According to ResearchAndMarkets,

      5/27/25 7:00:00 AM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care
    • NewGenIVF Introduces NewGenSort to Support Men's Reproductive Health Across Asia

      BANGKOK, May 07, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on the integration of its recently acquired MicroSort® technology. The strategic integration of this technology – which the company has rebranded to NewGenSort – marks a significant advancement in the company's mission to provide comprehensive, cutting-edge reproductive solutions to couples and individuals throughout Asia. NewGenSort enables the separation of X and Y chromosome-bearing sperm cells prior to fertilization procedures. I

      5/7/25 8:00:00 AM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care

    $NIVF
    Leadership Updates

    Live Leadership Updates

    See more
    • NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

      Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane

      2/20/25 6:00:00 AM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care

    $NIVF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Chardan Capital Markets Llc claimed ownership of 1,569,000 units of Class A Ordinary Shares (SEC Form 3)

      3 - NewGenIvf Group Ltd (0001981662) (Issuer)

      11/13/24 9:16:27 PM ET
      $NIVF
      Misc Health and Biotechnology Services
      Health Care